Jing joins Refuge Biotechnologies as Chief Business Officer following a wealth of experience in global healthcare transactions and financings. He has spent over a decade in pharmaceutical, biotech and healthcare finance working on a full spectrum of strategic transactions at big cap pharma, investment banking, private equity and venture capital.
Jing was previously a Director at Novartis in Basel, Switzerland, leading strategic transactions, acquisitions and divestments totaling over 70 billion dollars. Prior to Novartis, he has also worked in London with Rothschild and Barclays Capital covering a wide range of global healthcare M&A and financings. Jing was most recently head of the healthcare franchise at ICBC RT Capital, a large international private equity and venture capital fund based in Beijing, China, and remains a Venture Partner with them.
Jing graduated in Medicine from Queens’ College, University of Cambridge.